Podcasts about quantum health

Join us on the latest episode, hosted by Jared S. Taylor!Our Guest: Dan D'Orazio, CEO at Sage Growth Partners.What you'll get out of this episode:Access Program & Fee-for-Service Disruption: New regulatory and payment guidance signals a major shift away from fee-for-service toward market-driven healthcare reform.PBM Reform & Transparency: Accelerating policy changes aim to increase transparency and reshape pharmacy benefit management.AI: From Hype to Practicality: The industry is moving from AI excitement to enterprise-level use cases in clinical, revenue cycle, and administrative workflows.Interoperability & Data Liquidity: Data liquidity remains a central priority, with interoperability still an unresolved industry-wide challenge.The Fax Paradox: Despite AI momentum, fax remains deeply embedded in healthcare workflows—now increasingly moving to the cloud.To learn more about:Website http://www.sage-growth.comLinkedin https://www.linkedin.com/company/sage-growth-partners/Our sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

Dr. Suelyn Hall is a board-certified urologist with over 20 years of experience as a respected surgeon and educator, currently teaching adult and pediatric urology residents. She earned her medical degree from New York Medical College and completed her residency at Westchester County Medical Center.She is the founder of Quantum Health and Wellness Center and is fellowship trained through University of South Florida Academy of Anti-Aging Medicine. Driven by a passion for preventative health and sexual wellness, Dr. Hall blends traditional urology with integrative and functional medicine to help people change the way they age and achieve optimal health.She is also the author of How to Get Ahead, an eye-opening guide that explores male pleasure through anatomy, psychology, mental health, and emotional well being, revealing how stress, self image, upbringing, and past experiences all shape desire and intimacy. Part science and part sensuality, the book offers a deeper understanding of what truly drives connection.Dr. Hall's approach focuses on optimizing health through nutrition, exercise, weight loss, hormone balance, and restorative therapies, guiding patients toward lasting vitality and their best possible well being.

Host Dr. Davide Soldato and guests Dr. Kerin Adelson and Dr. Maureen Canavan discuss JCO article "Association Between Systemic Anticancer Therapy Administration Near the End of Life with Health Care and Hospice Utilization in Older Adults: A SEER Medicare Analysis of End-of-Life Care Quality," highlighting adverse outcomes for patients who receive any type of systemic anticancer therapy(SACT) at EOL (end of life) and the need for better communication between oncologists and patients regarding expected risk and benefits of such treatments to properly align goals-of-care. TRANSCRIPT Dr. Davide Soldato: Hello and welcome to JCO After Hours, the podcast where we sit down with authors from some of the latest articles published in the Journal of Clinical Oncology. I am your host, Dr. Davide Soldato, medical oncologist at Ospedale San Martino in Genoa, Italy. Today, we are joined by JCO authors Dr. Maureen Canavan, epidemiologist and associate research scientist at Yale Cancer Outcomes, Public Policy and Effectiveness Research Center; and by Dr. Kerin Adelson, Chief Quality and Value Officer, medical oncologist, and clinical researcher on health services and clinical care delivery at MD Anderson Cancer Center. In the manuscript "Association Between Systemic Anticancer Therapy Administration Near the End of Life With Health Care and Hospice Utilization in Older Adults: A SEER-Medicare Analysis of End-of-Life Care Quality." that you recently published in the JCO, you performed an analysis that included more than 30,000 older adults in the SEER-Medicare database, and you observed that 7.6% of these patients received any systemic anticancer medication within 30 days of death. So, I wanted you to explain why you thought that this was a priority right now, and whether there was any previous data that was published in the literature, and if you think that there was any significant gap in the literature that led you to the research you just published. Dr. Kerin Adelson: We have published a series of articles looking at real-world trends  in patterns of care, particularly related to systemic anticancer therapy at the end of life. This has been gaining increasing focus in recent years because of the understanding that when patients stay on systemic anticancer therapy, that is often a surrogate for a lack of goal-concordant care. So, patients who continue to receive systemic therapy have worse quality of life, are more likely generally to have a medicalized death, and less likely to use hospice. And what our prior work has shown is that more and more we are seeing patients using immunotherapies and targeted therapies towards the end of life. No prior work had really comprehensively examined whether these novel therapies were associated with those same patterns of care increases in acute care utilization and decreases in hospice. Dr. Davide Soldato: So basically, the data that we had up until that point was mostly with cytotoxic chemotherapy, and the emergence of this new treatment, which frequently are thought to be less toxic and so less problematic also in the end of life, led to this research. Is that correct? Dr. Kerin Adelson: Correct. Dr. Maureen Canavan: I would also build on that. I think that as the landscape of cancer care changes, it is important to really understand the availability of treatments, but then also, as Kerin noted, it is important to focus on goal-concordant care. We have established literature, studies we have done and some other studies that have looked at cytotoxic chemotherapy, but with the emergence of these targeted therapies, we really did not know a few things. We did not know the rates of utilization in a large national population, and how that was associated with these elements of medicalized death like ED use, hospitalizations, acute care use. So this was really a question that we had going into it. How can we expand the knowledge base so that both patients and providers can be more cognizant when thinking about goals of care conversations and ensuring that that is in place? Dr. Kerin Adelson: And our work has kind of evolved to answer some critical questions. So, one of our early papers looked at different rates of systemic anticancer therapy at the end of life, and that is where we showed that we were seeing a lot more immunotherapy and targeted therapy. And then we asked the question, well, oncologists generally when they give these treatments, they are hoping that those treatments are going to work and help the patients live longer. So we did another paper where we actually looked at practices who were more aggressive near the end of life and whether they had better overall survival than practices that were less aggressive, accounting for the fact that there could be populations of patients who benefited. And in fact, we showed there was no survival difference. So then this paper sort of answered the question: Well, if it is not having benefit, is this treatment actually doing harm? And this study gets at that question: What are the harms of continuing patients on therapy past the point of benefit? Dr. Maureen Canavan: And I think building off of that, the use of the SEER-Medicare database is a quite robust database. So in this, we have very specific data we can track. We can track the exact type of treatment they had, you know, was it a targeted therapy? Was it immunotherapy? So looking at those subclasses of therapy. We were also able to directly link it within that time frame to the acute care utilization, a limitation that we had in some of our previous work that that data was not always available. So it is more focused in the sense that we were looking at older adults, so patients 66 years of age and older, but we were able to get those individual metrics. So to Kerin's point, we did not see the survival benefit. What do we see then for these medicalized death elements? So the higher rates of all of them across the board. Dr. Davide Soldato: So coming back to the cohort and to the data that you utilized, Dr. Canavan mentioned the use of the SEER system to analyze these data. You already mentioned that you included mostly older adults, so those aged 66 and more. And also there was a little bit of restriction regarding the fact that the patient needed to be covered by Medicare in the last year of death concerning Part A and Part B, and the last 30 days from death concerning Part D. So I just wanted to ask a little bit of a question regarding these findings and whether you think that we also need additional work, especially in the younger population because I think it is something that all of us who work in oncology have seen. The aggressiveness, and this is also something that you showed in your data, tends to increase as the age of the patient tends to decrease. So we tend to be more aggressive towards younger patients. So just a comment on that on the population and generalizability of the findings. Dr. Maureen Canavan: Yeah, I will start with the data question element. Thank you. I think there are a few things to point out for that. So in terms of the restriction to ensure that they had continuous Part D coverage, that was necessary for us to track their oral medication use during that time. So kind of an easy response. The Part A, Part B requirement, it is actually pretty widely used in studies of SEER-Medicare data, and that is you want to establish the patient population, that they are not getting treated with another insurance provider in some way that you are not able to track. So that ensures that we can track not only their systemic anticancer therapy use but also when we are trying to make sure that we are controlling for confounders like chronic conditions and stuff, we are able to track the presence of chronic conditions. So we wanted to make sure we were not biasing the data, so I think that was an important consideration. You do point out very wisely that there are then limitations with the generalizability, and I think we would be lacking if we did not account for that. But I think it is important to establish this baseline relationship association, and then you can step out, we will say, to more diverse populations. So I think we could potentially maybe try to relax the timeline to see if people that might have influx in and out of the Medicare system are still seeing those same rates. I think it is likely they would. But I think to the bigger point that you bring up is that establishing this within the older adults where, you know, we do see as they get older maybe less rates of systemic therapy, extending it to the younger population. There is a challenge with that in that just that data is not available to the robust level that SEER-Medicare is. Both Kerin and I have noted that there is the possibility to look within one specific insurance provider type. Again, recognizing the limitations of the generalizability, but always slowly pushing the needle, finding out more about younger adult populations. And I think this is maybe in an ideal world, but setting the precedent that we really do need to track this on a national scale within younger adults because they do have the need. We do see these higher rates of utilization, and really making sure again with the mindset always of the best interest of patients and the most informative to providers in how we are looking at care. So I think generalizability is definitely a goal. However, there are limitations of the availability of data for younger populations and I think that they are a necessary restraint that all researchers should acknowledge. Dr. Kerin Adelson: Yeah, I think it is important for our audience to understand that health services research and large database research is really limited by what databases are available and what are the characteristics of those databases. So we have done a lot of work in an electronic health record database, and there you can get certain kinds of granularity that you may not be able to get in a payer or a claims-based database. But what you do not get is that comprehensive look at, say, what happens if a patient goes to another practice. Claims-based databases offer you that, but research on US populations is limited by our payment system. So when you look at younger patients, there are so many different insurance companies that when you are trying to get that comprehensive view, it can be hard or very expensive actually. These commercial insurers will sell their data to different databases. So for us, the largest single payer in the United States is the US government, and that is for patients who are over age 65, and that is why you see lots of US-based studies done in the Medicare population. Interestingly, a recent paper by a Canadian group showed very, very similar patterns. It was a significantly smaller study but, right, Canada is a single-payer system and so they were able to really look at all ages, and we did see the same patterns of care in a different payment system. Dr. Davide Soldato: Going back a little bit to the type of treatments that were observed in your manuscript, so we start from a 7.6% of patients who received any type of systemic anticancer therapy within 30 days from death. And when we split the different categories that you analyzed, which I think is a very strong aspect of your manuscript, we see that more or less 50% of the patients received chemotherapy, 20% more or less received immunotherapy, more or less 20% targeted therapy, and then there is a combination of those agents. So just wanted to have a little bit of your opinion compared also to the data that you already published and that you mentioned before. Was this in line with previous data? Was there anything surprising about this? We saw a little bit of a raise in the use of immunotherapy and targeted therapy as you were saying, but still, there is a very high proportion of chemotherapy, 50%. Dr. Kerin Adelson: So I think that really, really reflects the time period in which we studied where immunotherapies were gaining ground. There was tons of excitement and we were seeing this shift. I bet if we do the same study in five years that chemotherapy percent may even go down to half, and we are going to see more and more targeted and immunotherapies, and that is just reflecting the pattern of drug discovery that we are seeing. Dr. Davide Soldato: Coming to the real question that you wanted to answer with this manuscript, so is systemic anticancer therapy associated with worse outcomes in terms of healthcare utilization and use of hospice resources? Was there any hint that for example immunotherapy was related to less of these adverse outcomes? Dr. Kerin Adelson: So I will be honest, I was a little bit surprised that the combination of chemotherapy and immunotherapy was that much more strongly correlated with acute care use at the end of life. You know, I had really thought most likely that what we would see were similar rates. And we did. Each different type of systemic anticancer therapy was associated with significantly higher odds of ending up in the hospital, going to the ICU, dying in the hospital, going to the ED. But that group that got dual therapy was that much higher, you know, over three times the risk. And that surprised me because what it suggested is that there is likely a component of treatment toxicity that is leading to some of the acute care use. It is not simply just a constellation of patients who have not yet transitioned towards hospice or palliative care or end-of-life care who are then more likely to end up in the hospital. But the fact that we see a difference between, say, single-agent immunotherapy and dual combination with chemotherapy does suggest that the treatments are actually contributing to some of what we are seeing. Dr. Davide Soldato: But still, all of the treatments that you evaluated were still associated with higher healthcare utilization. Like there was no signal that, for example, giving immunotherapy at the end of life was not associated with these adverse outcomes. Correct? Dr. Kerin Adelson: Correct. And you will find oncologists out there who will say, actually, these treatments are so good that they might actually lower rates of hospitalization because they keep patients healthy. And certainly, that may be true upstream or earlier in the course of disease, but at the end of life, any form of systemic anticancer therapy is really a surrogate marker for lack of transition towards what is likely appropriate end-of-life therapy. And I just want to point out that time spent in the hospital, going back and forth to invasive procedures, going to the intensive care unit, even going back and forth to an infusion center, that is time that is not spent at home with loved ones for people who have very little time left to live. Dr. Davide Soldato: Thank you very much. That was exactly the point that I wanted you to stress because I think it is really the most important message that we can get as oncologists from this manuscript. Like there is no treatment that is not associated with potentially harming our patient and, as you were saying, taking off time with loved ones in a critical period of the life of these individuals who have been diagnosed and treated for cancer. So, basically what we saw in the paper was a 7.65% utilization of systemic anticancer therapy. And I might imagine that for some oncologists or for some hematologists that might not actually be that much. Like they could potentially say, "Okay, but it is like 7%, it is not that high. I would have expected something higher." So I just wanted a little bit of perspective regarding also quality metrics that we have available for these types of indicators at end-of-life care. What would be the appropriate percentage of people receiving any type of treatment within 30 days from death? Dr. Maureen Canavan: A couple caveats, as a data person I always like to give those. This was among all cancer patients, so not necessarily patients that had been on active treatment. So I think that number was actually quite lower than when we looked in another study about patients that had chemo within the last year, so on, you know, active treatment. So I think that is an element to take into consideration is that those numbers will vary based on who your denominator population is. So that is important to consider. Additionally, the National Quality Forum, they call for reducing rates of systemic therapy at end of life. But I think they, similar to how I would be, are cautious to point out this is the exact number, or it should be zero. Because there are cases where you have to go in line with patient preferences. And if a patient is very adamant that they want to continue treatment, that needs to be a decision that comes between them and their provider. So, you know, the zero, though sounding ideal to us who want to encourage transitions and encourage goals of care conversation is a nice number, it is not a realistic. So, to evade your question completely, I do not think there is a set number. But the goal is to make sure that both patients, providers, everyone is informed and is making the best holistic decision. So there is this natural tendency, I think, to keep fighting both for the patient and the provider to try to beat something, but recognizing the point at which we are beyond a benefit of treatment and what would be most beneficial to the patient in terms of getting back to that idea of, you know, the time with their families and whatnot. So is the number zero? No. Could it probably be lower than we have? I think yes, definitely. Dr. Kerin Adelson: I completely agree with everything Dr. Canavan said. I think one of the other challenges is that this data isn't being tracked and publicly reported across the world. And so what that optimal rate is, is a little unclear. We see different rates also depending on the population included. So one of the things Dr. Canavan said is our database included patients who were likely treated long ago for cancer and cured of their cancer. So they were less likely to die on systemic therapy. But until everybody starts tracking and reporting, it is really hard to know where we are as a country or really as a global population, and then what are the bars that we want to achieve in driving down the rates. I think some data shows that probably something in the range of 10% or below, you know, for patients who have more active cancer is probably where we should be going and driving towards. But until we have more public reporting of these metrics and consistency in how we measure them, it is really hard to come up with a single number. Dr. Davide Soldato: I have the impression that sometimes there is also a little bit of difficulty for the oncologist or the hematologist to really understand who are the patients who are approaching end of life. So there has been some data and you also report some of them in the discussion of the manuscript regarding, for example, prompts inside of the electronic health records or the use of artificial intelligence to try to predict what is the disease course. So just wanted a little bit of perspective if you think that these tools could potentially be helpful and if you think that we will be able at a certain point to implement them in routine clinical care. Dr. Kerin Adelson: I have been working on trying to do this actually at MD Anderson and coming up with a really reliable data tool that will tell us who are the patients who are going to die in short order after receiving systemic anticancer therapy. And it is not that easy, I will say. So, you know, I think we all want this amazing machine learning model that is incredibly reliable. But like any statistical test, there are problems, right? So a very sensitive test that is going to identify high, high risk of dying at the end of life is going to be compromised by false positives. And when an oncologist knows that the test might be a false positive, it becomes very hard for them to take action on it. Similarly, you know, a very, very specific test is going to be compromised by false negatives. So in that case, you could end up having patients who are at risk for dying and still treating them with chemotherapy. And so, you know, I think in the end we need some tools. It will be great if machine learning becomes very reliable and we have the right structured data elements in our electronic health records to give these reliable prediction tools. But I think there are some basic things that we all know, and those are the markers of chronicity of cancer. So patients who have had multiple lines of therapy already, right? Past the point of clinical trial benefit. Patients who have lost significant amounts of weight. Patients who are not getting out of bed and have worse performance status. Patients who are increasingly confused, right? And not mentally engaging the way they did previously. Those markers have been shown in numerous publications by a colleague of mine, David Hui and others, to really be pretty strong predictors, and they resonate with clinicians more than a machine learning score might. You know, I think when clinicians do not understand what the elements in a machine learning tool are, they are less likely to trust it and more likely to say, "Oh, it is a false positive or a false negative." But very few clinicians can argue against the fact that the patient who hasn't gotten out of bed in two weeks is somebody who is less likely to benefit. Dr. Davide Soldato: Dr. Adelson, I would like to close this podcast and I would like to thank you again for joining us today. Dr. Maureen Canavan: Thank you so much. Dr. Kerin Adelson: Thank you so much for having us. Dr. Davide Soldato: Dr. Canavan, Dr. Adelson, we appreciate you sharing more on your JCO article titled "Association Between Systemic Anticancer Therapy Administration Near the End of Life With Health Care and Hospice Utilization in Older Adults: A SEER-Medicare Analysis of End-of-Life Care Quality." If you enjoy our show, please leave us a rating and review and be sure to come back for another episode. You can f ind all ASCO shows at asco.org/podcast. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.    Disclosures Kerin AdelsonStock and Other Ownership Interests: Carrum Health Consulting or Advisory Role: Abbvie, Quantum Health, Gilead SciencesPatents, Royalties, Other Intellectual Property: Genentech Other Relationship: Genentech/Roche Employment: Emilio Health/Brightline Health(An Immediate Family Member) Stock and Other Ownership Interests: Emilio Health/Brightline Health, Lyra Health (An Immediate Family Member)

Join us on the latest episode, hosted by Jared S. Taylor!Our Guests: Dan D'Orazio, CEO, Sage Growth Partners, and Christina Speck, Chief Solutions & AI Officer, Sage Growth Partners.What you'll get out of this episode:Strategic AI Adoption: Leaders must align AI tools with real business problems, not just adopt technology for its own sake.Enterprise Change Management: Success hinges more on people and process readiness than on the AI technology itself.Human + AI Synergy: The rise of “HI + AI” and “HSI” (Humanist Super Intelligence) models puts empathy at the center of AI innovation.Clinical & Administrative Focus: Real AI excitement lies in automating repetitive administrative tasks, with clinical applications gaining cautious momentum.Sage's Growth-Centric AI Model: From readiness to impact, Sage Growth Partners tailors AI strategies to support each client's growth journey.To learn more about:Website http://www.sage-growth.comLinkedin https://www.linkedin.com/company/sage-growth-partners/Our sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

In this dynamic episode, we explore the deeper architecture of the human energy field through the lens of quantum health and informational medicine. Dr. Laura Petkunaite joins us to reveal how biophotons, electron flow, inherited emotional fields, and subtle-body signatures shape our health, behaviour, and patterns. We explore and discuss how the multidimensional system operates - and how coherence becomes the foundation for real transformation.Epsisode highlights: • What quantum health actually means • The role of biophotons, electron flow, and informational load • How trauma patterns replicate through emotional and mental fields • Transgenerational imprints and inherited emotional signatures • How to read the hidden architecture of your field • Why the body repeats old patterns (and how to break them) • The difference between physical, emotional, mental and subtle bodies • How practitioners can avoid observer interference • The real meaning of coherence across the human system • How informational medicine works in practiceLearn more: frequencyinformedassessment.comEnjoyed the episode? Rate & review on Apple Podcasts Follow on Spotify or YouTube Train in Energy Healing Step into your mastery. Learn to facilitate deep, precise, and truly transformative healing experiences. Registration now open - our next EHT-100 Training begins March 2026, live and online. Discover the training → Find Your Energetic Blueprint Not sure where to start? Take the quiz: What's Your Field Type? Reveal your strengths and learn how your energy field shapes your life and relationships.

Join us on the latest episode, hosted by Jared S. Taylor!Our Guest: Yaw Fellin, Senior Vice President and GM, UpToDate Clinical Decision Support and Provider Solutions at Wolters Kluwer Health.What you'll get out of this episode:How UpToDate is making clinical decision support conversationalWhy validation, quality, and expert oversight are essential in AI toolsThe growing impact of workflow integration and ambient technologiesKey takeaways from HLTH 2025, including partnerships and customer momentumThe shift from AI hype to real-world clinical impactTo learn more about :Website https://www.wolterskluwer.com/en/health Linkedin https://www.linkedin.com/company/wolters-kluwer-health/Guest Linkedin https://www.linkedin.com/in/yaw-fellin-470a5621/Our sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

Lisa Fischer and Quantum Biology Collective's Meredith Oke dive into the revolutionary world of quantum biology and circadian rhythm to uncover the true foundation of optimal health. Meredith shares her journey from chronic fatigue to discovering how proper light exposure is key, not just food and exercise. Learn how light acts as medicine to heal chronic illness, why conventional medicine (and the supplement industry) prioritizes profit flow over these vital truths, and simple, practical steps you can take to "get your light right" and reclaim your energy right now.     WEBSITE: https://qbcpod.com/home-page/     INSTAGRAM: https://www.instagram.com/quantumbiologycollective/     FACEBOOK: https://www.facebook.com/QuantumHealthTV     YOUTUBE:  https://www.youtube.com/@QuantumBiologyCollective     EPISODE SPONSOR:  https://www.ralstonfamilyfarms.com/     EPISODE SPONSOR:  https://www.akelscarpetone.com/     LISA'S LINKS:     Lisa Fischer Said Academy:  https://lisafischersaid.com/academy/     Website:  lisafischersaid.com     For more information on group intermittent fasting  coaching with Lisa, email fasting@lisafischersaid.com     For more information on one-on-one or group health coaching with Lisa, email healthcoaching@lisafischersaid.com     Podcast produced by clantoncreative.com    

This episode was sponsored by Quantum Health. Katie Adams, associate editor at MedCity News, interviewed Shannon Skaggs, chief AI officer at Quantum Health, about how AI is reshaping the care navigation and benefits guidance world.   Episode Resources Connect with Arundhati Parmar aparmar@medcitynews.com  https://twitter.com/aparmarbb?lang=en https://medcitynews.com/ Connect with Shannon Skaggs https://quantum-health.com/shannon-skaggs/  https://www.linkedin.com/in/shannonskaggs/?skipRedirect=true    Review, Subscribe and Share If you like what you hear please leave a review by clicking here   Make sure you're subscribed to the podcast so you get the latest episodes. Click here to subscribe with Apple Podcasts  Click here to subscribe with Spotify Click here to subscribe with Podbean Click here to subscribe with RSS

We all know that essential inputs like diet and movement can make a huge difference in how you feel on a day-to-day basis. But have you ever thought about how light can impact your health? Today, you're going to learn the fascinating science of different light spectrums—including the ones present in sunlight and artificial light—and how they can improve or degrade your health.  On this episode of The Model Health Show, you're going to learn about light and circadian biology from Princeton-trained PhD, Dr. Alexis Cowan. Dr. Cowan is passionate about helping folks harness the powerful science of light, biophysics, and mitochondrial biology to optimize their health and performance.  You're going to learn about why sunlight is essential for human health, what non-native EMFs are and how they impact your biology, and the relationship between light and mitochondria. This episode is packed with mind-blowing science that you can use to uplevel your health immediately. I hope you enjoy this interview with Dr. Alexis Cowan!  In this episode you'll discover: What circadian biology is. (5:04) The primary timekeepers for circadian biology. (5:40) How blue light from your devices affects your health. (6:52) The relationship between sunlight, melatonin, and cortisol. (7:17) What to consider about how your windows filter sunlight. (9:12) Why total brightness matter for human biology. (12:06) The fascinating connection between light and hunger. (18:57) What melanin does in your body. (27:18) How red light therapy impacts mitochondria. (34:50) The surprising science of how darkness regulates your biology. (40:48) A conversation on radiofrequencies. (42:13) Realistic ways to reduce your exposure to EMFs. (47:18) The shocking truth about EMFs in electric cars. (50:48) Why grounding is a powerful way to improve your health. (1:03:13) How to maximize the benefits of exercising outdoors. (1:20:23) Items mentioned in this episode include: WildPastures.com/model - Get 20% off every box plus an additional $15 off!  Piquelife.com/model - Get exclusive savings on bundles & subscriptions!  QuantumU - Save $100 on Dr. Cowan's course using code SHAWN!  Quantum Health by Dr. Alexis Cowan - Get your copy of the eBook! The Mitochondriac's Travel Companion - Get your copy of the travel eBook! The Incubator - Subscribe to Dr. Cowan's book club! Connect with Dr. Alexis Cowan Email / Podcast / Instagram / X This episode of The Model Health Show is brought to you by Wild Pastures and Pique. Get 100% grassfed and finished beef, pasture raised chicken, and other nutrient dense, regenerative meats. Sign up with my link to get 20% of for life, plus an additional $15 off your first box at wildpastures.com/model.   Go to Piquelife.com/model for exclusive savings on bundles & subscriptions on cutting-edge solutions for your head-to-toe health and beauty transformation.

Join us on the latest episode, hosted by Jared S. Taylor!Our Guests: Kenneth Young, CEO at Medecision and Mike Green, Managing Partner at Excell Healthcare Advisors.What you'll get out of this episode:Strategic Union for Scalable Impact: Medecision's acquisition of Excell aims to merge technology and consulting to unlock ROI and operational change.Data Quality as the Foundation: Leaders emphasize that without clean, integrated data, AI initiatives risk failure.Enabling Clinicians to Work Top of License: AI is used to minimize administrative burden and maximize patient-focused care.AI with Purpose, Not Hype: Real-world applications, not buzzwords, are driving conversations about AI's role in healthcare transformation.Rehumanizing Healthcare: Combining AI, data, and clinical insight to ensure the right care is delivered at the right time.To learn more about:Medecision Website https://www.medecision.com/ Medecision Linkedin https://www.linkedin.com/company/medecision/ Excell Healthcare Advisors Website https://www.excellha.com/ Excell Healthcare Advisors Linkedin https://www.linkedin.com/company/excellhealthcareadvisors/ Our sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

Join us on the latest episode, hosted by Jared S. Taylor!Our Guest: Dr. Ruben Amarasingham, Founder & CEO at Pieces.What you'll get out of this episode:Smarter Notes Launch: Pieces and Smarter Technologies join forces to launch Smarter Notes—a unified product blending clinical documentation with revenue cycle tools.Client Excitement: Health systems are eager to adopt the integrated solution, validating the strategic vision behind the merger.Fast-Paced Integration: Teams from both companies are actively collaborating to deliver a seamless, end-to-end clinical documentation experience.Strategic Impact: Smarter Notes positions itself to raise industry standards and redefine market expectations in healthcare tech.What's Ahead: Rollouts at client sites begin before year-end, aiming for impactful performance insights by early 2026.To learn more about Pieces:Website https://www.piecestech.com/ Linkedin https://www.linkedin.com/company/pieces-technologies/Our sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

Join us on the latest episode, hosted by Jared S. Taylor!Our Guests: Adam Mariano, President and General Manager at LexisNexis Risk Solutions & Don Woodlock, Head of Global Healthcare Solutions at InterSystems.What you'll get out of this episode:Why data fragmentation persists despite a decade of digital transformation in healthcare.Stakeholder-specific challenges from payers to providers, and how fragmentation impacts each differently.The human cost of incomplete records, from patient frustration to dangerous outcomes.What an identity-first strategy looks like, and why it's crucial for resolving fragmentation.How LexisNexis and InterSystems partner to unify healthcare data with innovative identity resolution.To learn more about:LexisNexis Risk Solutions Website http://risk.lexisnexis.com LexisNexis Risk Solutions Linkedin https://www.linkedin.com/company/lexisnexis-risk-solutions/InterSystems Website http://www.intersystems.com InterSystems Linkedin https://www.linkedin.com/company/intersystems/Our sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

Join us on the latest episode, hosted by Jared S. Taylor!Our Guest: Dr. Monika Roots, Co-Founder, President and CMO at Bend Health.What you'll get out of this episode:Personal Mission: Dr. Roots' drive to improve youth mental health care stems from her own childhood experience with a parent's mental illness.Bend + Lyra: The acquisition by Lyra Health enables a shared mission of whole-family mental health care with a strong emphasis on outcomes.Beyond Access: Dr. Roots debunks the myth that mental health is merely an access problem. It's also an execution challenge.AI & Mental Health: She addresses the increasing use of AI tools like ChatGPT for therapy and stresses the importance of clinical oversight.Policy Impacts: Cuts to Medicaid and MAHA regulations pose significant threats to youth mental health access and outcomes.To learn more about Bend Health:Website https://www.bendhealth.comLinkedin https://www.linkedin.com/company/bend-health/ Our sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

Join us on the latest episode, hosted by Jared S. Taylor!Our Guest: Leigh Burchell, Vice President of Policy and Government Affairs at Altera Digital Health.What you'll get out of this episode:Policy Veteran Insight: Leigh Burchell shares her experience navigating U.S. health IT policy since 2008, from the Obama era to today.Federal vs. State Chaos: Fragmented state-level regulations complicate compliance for health tech companies like Altera.Shift Toward Voluntary Action: CMS is leading current health IT policy with a lighter regulatory touch, favoring pledges over mandates.User-Centered Innovation Needed: Overregulation often ignores the actual needs of clinicians and patients using health IT.Hope for Standards-Based Progress: Burchell urges for thoughtful federal frameworks to replace inconsistent state initiatives.To learn more about Altera Digital Health:Website http://www.alterahealth.com Linkedin https://www.linkedin.com/company/altera-health/ Our sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

TODAY ON THE ROBERT SCOTT BELL SHOW: Jonathan Emord, Kimmel Canned, Cassidy Breaks from RFK, Fed Cuts Rates, Antifa Now Designated Terrorists, ABC Reporter Apologizes, Teen Antidepressant Scandal, Dr. Lisa Palmer, Quantum Health Summit, Insurers Still Covering COVID Shots, Naphthalinum and MORE! https://robertscottbell.com/kimmel-pulled-cassidy-breaks-from-rfk-fed-cuts-rates-antifa-now-designated-terrorists-abc-reporter-apologizes-teens-and-antidepressant-scandal-dr-lisa-palmer-quantum-health-summit-insurers-st/https://boxcast.tv/view/jonathan-emord-kimmel-canned-cassidy-breaks-from-rfk-fed-cuts-rates-dr-lisa-palmer-quantum-health-summit---the-rsb-show-9-18-25-bdratc387jhsie3ak6ch Please read this disclaimer carefully before you (“you”, “your”) use our [Your Website URL] website (“website”, “service”) operated by the [Your Business Name] (“operator”, “us”, “we”, “our”). Purpose and Character The use of copyrighted material on the website is for non-commercial, educational purposes, and is intended to provide benefit to the public through information, critique, teaching, scholarship, or research. Nature of Copyrighted Material Weensure that the copyrighted material used is for supplementary and illustrative purposes and that it contributes significantly to the user's understanding of the content in a non-detrimental way to the commercial value of the original content. Amount and Substantiality Our website uses only the necessary amount of copyrighted material to achieve the intended purpose and does not substitute for the original market of the copyrighted works. Effect on Market Value The use of copyrighted material on our website does not in any way diminish or affect the market value of the original work. We believe that our use constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the U.S. Copyright Law. If you believe that any content on the website violates your copyright, please contact us providing the necessary information, and we will take appropriate action to address your concern.

Join us on the latest episode, hosted by Jared S. Taylor!Our Guest: Kyle Swarts, President at aiHealth.What you'll get out of this episode:Solving Outpatient Coding Inefficiencies: aiHealth automates complex medical coding tasks, addressing staffing and process issues in the middle revenue cycle.Busting the AI Fix Myth: AI won't fix broken workflows; real change requires reimagining processes and cultural transformation.The BAA Roadblock: Outdated Business Associate Agreements (BAAs) create significant barriers to AI deployment in healthcare.Ambulatory Focus: aiHealth targets the growing outpatient market, following the migration of surgical procedures from hospitals to ambulatory centers.What's Next for aiHealth: The company is expanding into auditing and clinical documentation improvement while emphasizing strategic partnerships.To learn more about aiHealth:Website https://www.ai-health.io/ Linkedin https://www.linkedin.com/company/aihealth-io/Our sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

Join us on the latest episode, hosted by Jared S. Taylor!Our Guest: David Leo Fischel, Chairman & CEO at Stereotaxis.What you'll get out of this episode:Next-Gen Surgical Robotics: Stereotaxis pioneers the only commercial robotic system for endovascular procedures, revolutionizing catheter-based interventions.Precision with Magnetic Fields: Their unique approach uses magnetic fields for millimeter-level control of catheters deep inside the body.Focused Innovation: The company is investing heavily in improving accessibility, catheter design, and AI-driven clinical intelligence.Breaking Barriers: Stereotaxis is tackling both societal and mechanical limitations that have historically hindered robotics in vascular surgery.Platform Potential: CEO David Fischel envisions Stereotaxis as a foundational platform for a broader spectrum of procedures, similar to Da Vinci in laparoscopic surgery.To learn more about Stereotaxis:Website http://www.stereotaxis.com/Linkedin https://www.linkedin.com/company/stereotaxis/Our sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

Join us on the latest episode, hosted by Jared S. Taylor!Our Guest: Dr. Kit Kieling, Chief Medical Information Officer at SmarterDx.What you'll get out of this episode:Career Pivot Sparked by Adversity: A heart condition derailed Dr. Kieling's dream of becoming a fighter pilot, redirecting him toward a meaningful career in medicine.Clinical and Strategic Experience: He served over a decade in military medicine, later co-founding a health tech startup acquired before joining SmarterDx.Real AI, Not Just Buzzwords: He praises SmarterDx for building AI that mirrors clinical reasoning—going beyond slide-deck hype to actual hospital impact.Redefining the CMIO Role: At SmarterDx, Kieling amplifies clinical voices across product and strategy, guiding how data empowers care teams.Leveling the Playing Field with AI: He's excited about how AI can counterbalance payer algorithms and eventually support bedside care decision-making.To learn more about SmarterDx:Website https://www.smarterdx.com/ Linkedin https://www.linkedin.com/company/smarterdx/Our sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

Join us on the latest episode, hosted by Jared S. Taylor!Our Guest: Christopher Molaro, CEO at Neuroflow.What you'll get out of this episode:Neuroflow has grown to serve over 17 million users across all 50 states.The company acquired four organizations in two years, expanding its capabilities and reach.It launched BHIQ, an AI-driven product that identifies behavioral health risks using claims and EHR data.Neuroflow rebranded its mobile app as “Onward,” emphasizing its broader platform approach beyond mobile engagement.The company now embeds into existing healthcare workflows, minimizing friction and enhancing accessibility.To learn more about Neuroflow:Website https://www.neuroflow.com/ Linkedin https://www.linkedin.com/in/chrismolaro/Our sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

Ellen Kamhi talks with Dan Stachofsky, the founder of Essential Energy, member of the Holistic Leadership Council, host of the Quantum Health and Healing show on the Braveheart Nation platform, frequent speaker, and podcast guest, and is studying to be a Certified Functional Nutrition Counselor. He speaks on topics ranging from non-native electromagnetic frequencies and the effects on people and farms, nutritional and mitochondrial health, bioresonance and photonic therapy, and parenting for total family health.  https://essentialenergy.us

Join us on the latest episode, hosted by Jared S. Taylor!Our Guest: Michelle Turner, CEO & Founder at Here Now Health.What you'll get out of this episode:Personal Mission Meets Professional Expertise: Michelle Turner, CEO of Here Now Health, blends over a decade of virtual healthcare experience with firsthand foster care advocacy.Addressing Systemic Healthcare Gaps: Foster children often face long waits or outright barriers to care—Here Now Health aims to change that.Launching with Impact: The company debuts in Virginia with plans to expand across states by year-end, focusing on continuity in mental health services.Built by Lived Experience: More than 75% of Michelle's team have personal histories in the foster care system, ensuring empathy-driven, mission-aligned care.Scaling With Vision: Michelle is excited to measure success not just by clinical outcomes, but by family reunifications and fewer foster disruptions.To learn more about Here Now Health:Website https://www.herenow.health/ Linkedin https://www.linkedin.com/company/here-now-health/ Our sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

Join us on the latest episode, hosted by Jared S. Taylor!Our Guest: Joel Wright, President Pharmacy Services at VytlOne.What you'll get out of this episode:Rebranding with Purpose: VytlOne, formerly Maxor, repositions itself to better serve nonprofit health systems with comprehensive pharmacy solutions.From Cost Center to Profit Driver: Through 340B optimization, VytlOne transforms hospital pharmacies into top-performing profit centers.Technology and People Power: The ClearView analytics platform and pharmacy liaisons help reclaim lost prescription value and improve outcomes.Case Study Success: At Conway Medical Center, VytlOne's program led to a 65% reduction in readmissions and 98% patient satisfaction.Future Vision: Hospital pharmacies are poised to reemerge as central, cost-effective hubs of community healthcare.To learn more about VytlOne:Website https://vytlone.com/ Linkedin https://www.linkedin.com/company/vytlone/Our sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

Join us on the latest episode, hosted by Jared S. Taylor!Our Guest:  Michael Dalton, Founder and CEO at Ovatient.What you'll get out of this episode:Michael Dalton founded Ovatient after leading virtual care strategies at Metro Health and Summa Health.Ovatient emphasizes an "Epic-first" approach to ensure seamless integration for patients and providers.Their care model is "virtual-first, local always, never virtual-only," focusing on connected and high-quality care.Ovatient provides integrated whole-person care, including behavioral health and weight management.The company is structured as a nonprofit, but evaluating a hybrid model for future scalability and impact.To learn more about Ovatient:Website https://ovatient.com/Linkedin https://www.linkedin.com/company/ovatient/ Our sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

Join us on the latest episode, hosted by Jared S. Taylor!Our Guests: Jonathan Kaye, President & Bonnie Cassidy, Chief Operating Officer at Health Data Innovations.What you'll get out of this episode:HDI helps providers make claims data usable across all payer formats to power analytics and care delivery.Claims data fills critical gaps left by EMRs in value-based care models, especially for out-of-network care.HDI's tools standardize complex payer datasets, ensuring accuracy and speed.Trusted by clients and tech leaders like Epic to handle high-volume, sensitive data integrations.The company continues to scale its platform to send validated data to multiple tech partners seamlessly.To learn more about Health Data Innovations (HDI):Website https://www.hd-innovations.com/ Linkedin https://www.linkedin.com/company/health-data-innovations-inc-/Our sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

Join us on the latest episode, hosted by Jared S. Taylor!Our Guest: Andrew Kobylinski, Co-Founder & CEO at Primary.Health.What you'll get out of this episode:Andrew Kobylinski, CEO & Co-Founder, shares the accidental founding and mission of Primary.HealthPublic health's digital gaps: why so much work is still done on paper, and how Primary.Health is solving itChallenges of funding and innovation in public health, and advice for investorsLessons from bootstrapping a $120M+ public health company without VC fundingThe future: collaboration between public and private sectors to reach underserved communitiesTo learn more about Primary.Health:Website https://primary.health Linkedin https://www.linkedin.com/company/primaryhealth/ Our sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

Join us on the latest episode, hosted by Jared S. Taylor!Our Guests:  Dr. Michael Gao and Dr. Joshua Geleris, Founders at SmarterDx.What you'll get out of this episode:SmarterDx helps hospitals fully capture patient journeys and maximize reimbursement through advanced AI technology.The founders, Dr. Michael Gao and Dr. Joshua Geleris, leveraged their backgrounds in medicine and data science to address inefficiencies in hospital revenue cycles.A critical pivot from concurrent to pre-bill review allowed SmarterDx to prove measurable value to hospitals and align incentives.The formation of Smarter Technologies, combining SmarterDx, Thoughtful AI, and Access Healthcare, creates a platform approach to solve broader revenue cycle challenges.A customer-centric mindset and deep healthcare expertise are central to SmarterDx's and Smarter Technologies' approach.To learn more about SmarterDx:Website https://smarterdx.com/ Linkedin https://www.linkedin.com/company/smarterdx/Our sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

Join us on the latest episode, hosted by Jared S. Taylor!Our Guest: Todd Dunn, CEO at Accuryn Medical.What you'll get out of this episode:Todd Dunn's unique path: from healthcare innovator and Accuryn customer to CEOThe enormous impact of acute kidney injury (AKI) in U.S. hospitalsHow Accuryn Medical digitizes kidney monitoring for earlier detection and interventionThe financial and patient care benefits of automating kidney data and documentationAccuryn's commitment to raising awareness and partnering with hospitals for better kidney outcomes.To learn more about Accuryn Medical:Website https://accuryn.com/ Linkedin https://www.linkedin.com/company/accuryn-medical/Our sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

Join us on the latest episode, hosted by Jared S. Taylor!Our Guest:  Dr. Jeffrey Wessler, CEO and Founder at Heartbeat Health.What you'll get out of this episode:Heartbeat Health delivers virtual cardiology care across all 50 states, targeting value-based organizations.Founder Jeffrey Wessler emphasizes the importance of pivoting based on impact and patient need.Initial challenges led to a major shift from consumer-focused care to high-impact cardiovascular treatment.Wessler discusses the future of cardiology, focusing on implementation of existing treatments at scale.Encourages clinicians interested in tech to reach out to startups, highlighting opportunities for cross-industry collaboration.To learn more about Heartbeat Health:Website https://heartbeathealth.com Linkedin https://www.linkedin.com/company/useheartbeat/Our sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

Join us on the latest episode, hosted by Jared S. Taylor!Our Guest: Kara Trott, Founder & Board Chair at Quantum Health.What you'll get out of this episode:Kara Trott founded Quantum Health, pioneering the field of healthcare navigation and care coordination.Her legal and consumer behavior background uniquely shaped Quantum's patient-centric model.Trott's leadership philosophy emphasizes empathy, curiosity, and employee empowerment.Quantum Health recently acquired Embold Health, expanding its impact across 8 million lives.Her new book No One Alone captures 25 years of leading and innovating in a resistant healthcare industry.To learn more about Quantum Health:Website https://quantum-health.com/ Linkedin https://www.linkedin.com/company/quantum-health/ Our sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

Join us on the latest episode, hosted by Jared S. Taylor!Our Guest: Amy Bucher, Chief Behavioral Officer at Lirio.What you'll get out of this episode:Precision Nudging & Personalization: Lirio combines AI and behavioral science to deliver targeted nudges that help patients start and maintain healthy behaviors.Scientific Rigor with Real-World Speed: Lirio's solutions are built on detailed, deliberate behavioral design processes that prioritize speed to impact and user testing.Redefining Personalization & Motivation: Most healthcare personalization lacks depth. Lirio emphasizes individualized, values-based communication to drive genuine engagement.Building Trust with Patients: Lirio fosters trust through transparency, tailored messaging, and respecting patient autonomy.Global Expansion & Scalable Impact: Lirio is launching interventions across Latin America, the Middle East, and Asia, with a vision of becoming the "air traffic control" for personalized health journeys.To learn more about Lirio:Website https://lirio.com/ Linkedin https://www.linkedin.com/company/lirio/Our sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

Join us on the latest episode, hosted by Jared S. Taylor!Our Guest: Adam Stansell, CEO at Axle Health.What you'll get out of this episode:Axle Health's Major Pivot: Transitioned from delivering home health services to licensing its proprietary operations software.Key Insight from the Field: A revealing moment with a thumbtack-based scheduling system sparked the shift in focus.Execution Challenges: Took a year post-pivot to gain traction, eventually 10x'ing revenue in 2024.Funding Milestone: Closed Series A led by F-Prime, aligning with investors with deep operational and domain expertise.Vision Beyond Health: Adam reflects on the societal need for objective truth in the age of AI and misinformation.To learn more about Axle Health:Website https://www.axlehealth.com Linkedin https://www.linkedin.com/company/axle-health/Our sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

Join us on the latest episode, hosted by Jared S. Taylor!Our Guest: Max Marchione, Co-Founder at Superpower.What you'll get out of this episode:Building a Healthcare Super App: Superpower offers an AI-driven healthcare membership that includes 100+ blood biomarker tests, data integration, and holistic care.Vision of Widespread Access: Aims to create a health membership as universal as Amazon Prime, making preventive healthcare accessible and affordable.Founder Insights on Innovation: Max Marchione emphasizes the importance of ignoring outdated advice and maintaining conviction in forward-thinking solutions.Entrepreneurial Wisdom: Advises founders to build businesses that are resilient to advancements like AGI, focusing on immediate revenue and customer obsession.Personal Routines and Hacks: Max shares his productivity rituals, nutritional hacks (including a powerhouse smoothie), and mental resilience mantra.To learn more about Superpower:Website https://superpower.com/ Linkedin https://www.linkedin.com/company/superpower-health/Our sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

Join us on the latest episode, hosted by Jared S. Taylor!Our Guest: Bill Taranto, President at Merck Global Health Innovation Fund.What you'll get out of this episode:Bill Taranto's Journey: From Johnson & Johnson to leading Merck's $600M GHI Fund focused on digital health and technology.Four Core Investment Areas: Drug discovery, clinical development, supply chain, and patient access/data.Portfolio Spotlights: Companies like Npower, Unnatural Products, Aerosafe Global, Cure AI, and Prognos are driving impactful innovation.Strategic Value of CVCs: Beyond capital, CVCs offer startups technical expertise, commercial agreements, and long-term support.Navigating Market Challenges: Insights on VC pullback, consolidation trends, and advice for startups on sustainable growth.To learn more about Merck:Website https://www.merck.com/ Linkedin https://www.linkedin.com/company/merck/Our sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

For more than twenty-five years, Quantum Health has been defining the field now known as healthcare navigation.  Our guest today is Kara Trott, whose goal was to ensure that no patient go through the difficult healthcare journey alone.  So she rose to the challenge, established a billion dollar plus business that is now an established leader in the healthcare space.  She writes about it in her memoir, “No One Alone: Humanizing Healthcare as an Outsider.”  Quantum Health has certainly made a difference in the lives of countless people, with dynamic leader Kara Trott at the helm!

Join us on the latest episode, hosted by Jared S. Taylor!Our Guest: Dr. Danna Chung, Chief Medical Officer at Ezra.What you'll get out of this episode:Dr. Danna Chung's Diverse Medical Journey: From health policy and community clinics to innovative startups and AI-driven diagnostics.Personal Catalyst for Joining Ezra: A family cancer diagnosis led Dr. Chung to seek better early detection tools, ultimately connecting her to Ezra.The Power of Early Detection: Emphasizes how early cancer diagnosis, especially via total-body MRI, can dramatically improve survival rates.Ezra's Tech-Driven Approach: AI-assisted scoring, personalized follow-up, and longitudinal health tracking make their screening more effective and responsible.Strategic Growth with Function Health: Recent acquisition boosts combined offerings of lab testing and imaging, expanding access and affordability.To learn more about Ezra:Website http://ezra.com Linkedin https://www.linkedin.com/company/ezrainc/Our sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

Join us on the latest episode, hosted by Jared S. Taylor!Our Guest: Patrick Quigley, CEO at Sidecar Health.What you'll get out of this episode:Patrick Quigley, an engineer-turned-entrepreneur, founded Sidecar Health from personal healthcare frustrations.Sidecar Health boasts a sub-1% claim denial rate, compared to the industry average of 19%.The platform empowers consumers with upfront pricing data and a Visa card to directly pay providers.Their model rewards members for choosing cost-effective care, returning an average of $1,000/year.Recent expansion includes Florida and large-scale adoption by jumbo employers like Koch Industries.To learn more about Sidecar Health:Website https://www.sidecarhealth.com Linkedin https://www.linkedin.com/company/sidecarhealth/Our sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

Join us on the latest episode, hosted by Jared S. Taylor!Our Guest: Jennifer Meyer, President of Commercial and Consumer Business at SonderMind.What you'll get out of this episode:Jennifer Meyer reflects on her two-decade journey in healthcare and how it led her to SonderMind.SonderMind is transitioning mental health care from access-focused to outcomes-driven.The company's innovative platform combines human-led therapy with AI-powered self-care tools.New areas of focus include women's mental health and support for chronic disease management.Product development at SonderMind is deeply informed by clinician feedback and emerging neuroscience.To learn more about SonderMind:Website https://www.sondermind.com Linkedin https://www.linkedin.com/company/sondermind/Our sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

Join us on the latest episode, hosted by Jared S. Taylor!Our Guest: Joseph Perekupka, CEO at Freespira.What you'll get out of this episode:28-Day At-Home Program: Freespira provides a medication-free treatment for panic disorder and PTSD, completed in the comfort of the patient's home.Personalized Support: Each patient is paired with a care coach ("Sherpa") to guide them and ensure clinical success.Focus on Accessibility: Freespira addresses care gaps by targeting underserved areas and ensuring insurance coverage.Regulatory Hopes: With evolving healthcare policies, Freespira aims to achieve nationwide reimbursement and accessibility.Life-Changing Results: Patients and health plans report transformative outcomes, from daily anxiety relief to rejoining family life.To learn more about Freespira:Website http://www.freespira.com Linkedin https://www.linkedin.com/company/freespira/Our sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

Join us on the latest episode, hosted by Jared S. Taylor!Our Guest: Elli Kaplan, CEO & Founder at Neurotrack.What you'll get out of this episode:Elli Kaplan's background spans government, finance, and healthcare, with a personal connection to Alzheimer's disease.NeuroTrack's digital cognitive tests provide accurate, stress-free screening for cognitive decline.The importance of early diagnosis and its impact on treatment outcomes for Alzheimer's patients.Future of digital cognitive health: growing support from healthcare systems and reimbursement for tests.To learn more about Neurotrack:Website http://www.neurotrack.com Linkedin https://www.linkedin.com/company/neurotrack/ Our sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

Join us on the latest episode, hosted by Jared S. Taylor!Our Guest: Andreas Cleve, Co-Founder & CEO at Corti.What you'll get out of this episode:Purpose-Built AI for Healthcare: Corti creates AI tools trained exclusively on healthcare data, ensuring higher quality and compliance compared to general-purpose models.Empowering Builders: Focused on equipping healthcare innovators—hospitals, startups, and life sciences—with specialized tools to build personalized, impactful solutions.Next-Gen Applications: Corti enables high-accuracy, speech-based interfaces for clinical reasoning, documentation, diagnostics, and revenue cycle management.Global Expansion and Impact: With half its customer base in North America and the rest in Europe, Corti aims to support a worldwide healthcare AI ecosystem.Events and Community Engagement: Catch Corti at HIMSS, VIVE, Vitalis, and SANTÉ Expo to connect and explore cutting-edge developments.To learn more about Corti:Website https://www.corti.ai Linkedin https://www.linkedin.com/company/corti/Our sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

Join us on the latest episode, hosted by Jared S. Taylor!Our Guest: Andrew Hines, Founder & CTO at Canvas Medical.What you'll get out of this episode:Canvas Medical empowers ambulatory practices with a powerful EMR that supports in-person, telehealth, and multi-setting care delivery.Developer tools enable rapid innovation, allowing practices to solve workflow issues and build custom extensions in under a day.Built for practices with a vision, Canvas Medical thrives in settings where teams want to iterate their care models using software and AI.Supports complex, high-touch care specialties like dementia, renal disease, pediatrics, and oncology with AI-powered optimization.Trusted by growing practices, Canvas Medical handles smooth transitions from legacy systems, helping clients future-proof their operations.To learn more about Canvas Medical:Website https://www.linkedin.com/company/canvas-medical/Linkedin https://canvasmedical.com Our sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

Join us on the latest episode, hosted by Jared S. Taylor!Our Guest: Roozbeh Ghaffari, CEO & Co-Founder at Epicore Biosystems.What you'll get out of this episode:Founder Spotlight: Roozbeh Ghaffari shares his journey from neuroscience research to leading Epicore Systems.Pioneering Wearables: Epicore Biosystems' GX Sweat Patch innovates real-time hydration and biochemical monitoring.Strategic Partnerships: Collaborations with Gatorade, PepsiCo, and Chevron drive deployment across industries.Global Growth & Impact: Series B funding fuels expansion into high-need regions like Asia and the Middle East.Future Vision: Advancing from hydration to stress, fatigue, and kidney health biomarkers.To learn more about Epicore Biosystems:Website https://www.epicorebiosystems.com/ Linkedin https://www.linkedin.com/company/epicore-biosystems/Our sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

Join us on the latest episode, hosted by Jared S. Taylor!Our Guest: Ross Harper, CEO & Co-Founder at Limbic.What you'll get out of this episode:Scaling Mental Healthcare with AI: Limbic uses regulated AI agents to bridge the gap between mental health needs and clinical supply, enabling autonomous intake, triage, diagnostics, and care delivery.Largest Deployment of Generative AI in UK Healthcare: Adopted by 40% of the UK's NHS, supporting over 420,000 patients.Proven Clinical Impact: Peer-reviewed research in top journals (e.g., Nature Medicine) shows improved outcomes, reduced wait times, and better access—especially for underserved communities.Rapid U.S. Expansion: In just 9 months, Limbic has gone live in 13 states with a roadmap to reach all 50.Next-Gen AI Tools Incoming: Limbic is introducing voice capabilities and deeper clinical insights to further improve engagement and care delivery.To learn more about Limbic: Website https://limbic.ai Linkedin https://www.linkedin.com/company/limbic-ai/Our sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

Join us on the latest episode, hosted by Jared S. Taylor!Our Guest: Tawny Hammett-Irvine, Founder & CEO at Mosona Health.What you'll get out of this episode:The Mosona Vision: Tawny Hammett-Irvine introduces Mosona Health, a platform integrating genomics, quantum biology, and bioelectric field mapping to transform health diagnostics and interventions.Personal Catalyst: A misdiagnosis in her mother's healthcare journey led Tawny to discover the power of AI and environmental triggers like black mold.Scientific Epiphany: Insights from quantum mechanics, AI, and bioelectricity led to her theory of a unified intelligence field shaping human health.Foundational Shift: Tawny proposes DNA as a quantum system interacting with a non-local intelligence field, controlled by bioelectricity.Call to Action: She invites visionary scientists, advisors, and investors to join the mission of rewriting the blueprint of modern medicine.To learn more about:  Guest LinkedIn: https://www.linkedin.com/in/tawnyhammett/Our sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

Employers should treat obesity as a chronic condition and support holistic programs that manage costs and provide ongoing GLP-1 support. In this episode, Dr. Stanley Crittenden, Chief Medical Officer at Quantum Health, discusses how his organization is driving change in healthcare delivery through navigation, technology, and a human-centric approach. He shares insights into Quantum Health's commitment to improving the member experience and clinical outcomes by addressing the complexities of healthcare and integrating AI technologies into their navigation approach. Dr. Crittenden also highlights the importance of pharmacy management, particularly in the rising cost of specialty medications and GLP-1s, and how Quantum Health is helping employers manage these challenges while prioritizing member well-being. Tune in to learn how Quantum Health is transforming healthcare through navigation, technology, and a focus on the whole person! Resources: Connect with and follow Dr. Stanley Crittenden on LinkedIn. Learn more about Quantum Health on their LinkedIn and website.

Enhancing healthcare navigation by combining technology with a human touch reduces costs, improves patient experiences, and promotes sustainable innovation. In this episode, Zane Burke, CEO of Quantum Health, talks about leveraging technology and human connection to enhance healthcare navigation. Zane discusses Quantum Health's pharmacy navigation solution, which reduces pharmacy costs, especially for specialty medications, by offering cost-effective alternatives at the point of care. This approach aims to minimize friction, improve member experiences, and enhance provider knowledge. He also talks about expanding solutions to surgery and oncology, utilizing reference-based pricing to manage costs.  Tune in to discover how Quantum Health is revolutionizing healthcare navigation with innovative technology and human touch! Resources: Connect with and follow Zane Burke on LinkedIn and X. Follow Quantum Health on LinkedIn and visit their website. 

Join us on the latest episode, hosted by Jared S. Taylor!Our Guest: Dr. Jim Bonnette, Chief Medical Officer at 86Borders.What you'll get out of this episode:Siloed strategies fail—coordination and patient focus are critical.Overuse of vendors leads to confusion and poor patient engagement.Real-time data and personal interaction significantly boost outcomes.Quality outreach hinges on empathy, not just volume.Targeted member education drives both satisfaction and star ratings.To learn more about 86Borders:Website: https://86borders.com/ LinkedIn: https://www.linkedin.com/company/86borders/Our sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

Join us on the latest episode, hosted by Jared S. Taylor!Our Guest: Peter Donnelly, CEO & Co-Founder at Genomics.What you'll get out of this episode:Genomics' Mission: Founded in 2014, Genomics is bridging cutting-edge genetic research with real-world healthcare solutions.Actionable Insights: Advances now allow actionable health insights for ~70% of people via genetic testing.Strategic Partnerships: Collaborations with companies like Vertex and GSK use genetics to improve drug targeting and trial outcomes.Insurance Innovation: Life insurers are early adopters of genetics to promote longevity and healthier lives.The Future Is Now: With global health systems under pressure, predictive genomics is primed to shift care from treatment to prevention.To learn more about Genomics:Website: http://www.genomics.com/ LinkedIn: https://www.linkedin.com/company/genomics-ltd/Our sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

The premise behind the Carnivore Diet is to eat to our biological design: exposing ourselves to the beneficial and essential nutrients, and removing the harmful exposures.  However there are more essential and beneficial exposures beyond just meat, and there are harmful exposures besides plant toxins.  This episode takes a closer look beyond the best ditary exposures to what are some of the best overall exposures for your health as well.  Enjoy! Dr. Petra Davelaar is a naturopathic doctor specializing in Deutenomic medicine—a field that explores the role of deuterium (a heavy isotope of hydrogen) in human health. Her work focuses on how deuterium levels affect cellular processes, particularly mitochondrial function, and how reducing deuterium accumulation may support disease prevention and recovery. ​ Born and raised in the Netherlands, Dr. Davelaar moved to New York in her 20s. She earned her Doctor of Naturopathic Medicine degree from Bastyr University in California in 2016. After practicing in Santa Monica for several years, she now offers consultations via telemedicine. Since January 2021, her credentials have been recognized in Hungary and most other European countries. ​ Dr. Davelaar is also certified in functional medicine and nutrition. She has served as a peer reviewer for scientific journals such as Scientific Reports and Medical Oncology. ​ In addition to her clinical work, Dr. Davelaar has contributed to public education through lectures and podcasts, discussing topics like deuterium depletion, over-hydration, and their implications for health and disease. ​ For more information about her work or to schedule a consultation, you can visit her official website at drpetrad.com  

In this episode, I sit down with my friend and podcast partner, Carrie Bennett, to discuss the mistakes we made when first exploring circadian and quantum biology. We share personal experiences about what worked, what didn't, and how to apply these concepts in a practical way without feeling overwhelmed.  This conversation originally aired on the Quantum Conversations Podcast, so if you enjoy deep dives into quantum health, circadian biology, and everyday wellness, be sure to check it out. We hope you enjoy this fun and insightful discussion about our journey and the lessons we've learned along the way!Topics Discussed: What are some common mistakes we made when first practicing circadian and quantum biology?How sun exposure can impact health, and what did we learn from our experiences?What role do seed oils and aging play in overall wellness?How does light exposure, including infrared and blue light, affect our biology?What are some ways people tend to overcomplicate health, and how can we simplify our approach?Join us at the Return To Nature Retreat| https://www.carriebwellness.com/a/2148042503/mHRys8NMTimestamps: 00:00:00 - Introduction 00:03:55 - Too much sun 00:08:01 - UV light & sun exposure 00:11:52 - Haplotypes and sunshine 00:15:15 - Aging 00:18:33 - Clear blue blockers 00:20:07 - Redlight on water 00:24:34 - Lights at night 00:27:09 - Travel anxiety & overcomplicating health 00:31:37 - Grounding mats 00:34:34 - Traveling & sun exposure 00:38:10 - Return To Nature Retreat Sponsored By: Viva Rays | Go to vivarays.com & use code: YOGI to save 15%Black Lotus Shilajit | Visit: www.blacklotusshilajit.com and Use Code: SARAHK for 15% the entire site!Check Out The Quantum Conversations Podcast!This video is not medical advice & as a supporter to you and your health journey - I encourage you to monitor your labs and work with a professional!________________________________________Get all my free guides and product recommendations to get started on your journey!https://www.sarahkleinerwellness.com/all-free-resourcesCheck out all my courses to understand how to improve your mitochondrial health & experience long lasting health! (Use code PODCAST to save 10%) -  https://www.sarahkleinerwellness.com/coursesSign up for my newsletter to get special offers in the future! -https://www.sarahkleinerwellness.com/contactFree Guide to Building your perfect quantum day (start here) -https://www.sarahkleinerwellness.com/opt-in-9d5f6918-77a8-40d7-bedf-93ca2ec8387fMy free product guide with all product recommendations and discount codes:https://www.sarahkleinerwellness.com/resource_redirect/downloads/file-uploads/sites/2147573344/themes/2150788813/downloads/84c82fa-f201-42eb-5466-0524b41f6b18_2024_SKW_Affiliate_Guide_1_.pdfMy Circadian App - AppleMy Circadian App - AndroidMy Circadian App - Youtube